p53 protein expression and oestrogen and progesterone receptor status in invasive ductal breast carcinomas

Cytopathology

Volumn 12, Issue 3, 2001, Pages 197-202

  Ioakim Liossi, A ^a,d   Karakitsos, P ^a   Markopoulos, C ^b   Aroni, K ^c   Athanassiadou, P ^c   Delivelioti, K ^a   Athanassiades, P ^c   Vaiopoulos, G ^c  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b 2Nd Propedeutic Surgical Clinic   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d NONE   (Greece)

Author keywords

Ductal breast carcinoma; Imprint cytology; Oestrogen receptor; p53 protein; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DO 7; PROGESTERONE RECEPTOR; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034972061     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2001.00315.x     Document Type: Article

References (24)

1. Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumors
2. The protooncogene p53 can act as a suppressor of transformation
3. Genetic analysis of human esophageal tumors from two high incidence geographic areas: Frequent p53 base substitutions and absence of ras mutations
4. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy
5. The p53 tumor suppressor gene
6. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
7. Histological grading and prognosis in breast cancer. A study of 1,409 cases of which 359 were followed for 15 years
8. The clinical utility of the immunocytochemical detection of p53 protein in cytological specimen
9. Improved sensitivity in the measurement of estrogen receptor in human breast cancer
10. Immunohistochemical detection of p53 protein in mammary carcinoma: An important new, independent indicator of prognosis
11. Genetic basis for p53 overexpression in human breast cancer
12. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients
13. p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study
14. Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biological parameters in primary breast carcinoma
15. Expression of proliferating cell nuclear antigen, Ki-67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytological samples of breast cancer: An immunochemical study with clinical, pathological and histologic correlations
16. Diagnostic associations of p53 immunostaining in fine needle aspiration cytology of the breast
17. p53 protein expression in human breast carcinoma: Relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression and estrogen receptor
18. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in nodenegative breast cancer
19. p53 expression in breast cancer
20. p53 mutations occur in aggressive breast cancer
21. Expression of p53 protein in infiltrating and in situ breast carcinomas
22. p53 quantitative immunocytochemical analysis in breast carcinomas
23. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
24. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer